Radiological semantics discriminate clinically significant grade prostate cancer

被引:8
|
作者
Li, Qian [1 ,2 ]
Lu, Hong [1 ,2 ]
Choi, Jung [3 ]
Gage, Kenneth [3 ]
Feuerlein, Sebastian [3 ]
Pow-Sang, Julio M. [4 ]
Gillies, Robert [2 ,3 ]
Balagurunathan, Yoganand [3 ,4 ,5 ]
机构
[1] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Dept Radiol, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China
[2] HLeeMoffitt Canc Ctr, Dept Canc Physiol, Tampa, FL USA
[3] HLeeMoffitt Canc Ctr, Dept Radiol, Tampa, FL 33612 USA
[4] HLeeMoffitt Canc Ctr, Dept GenitoUrol, Tampa, FL 33612 USA
[5] HLeeMoffitt Canc, Dept Biostat & Bioinformat, Quantitat Sci, Tampa, FL 33612 USA
关键词
Prostate cancer; Pirads; Semantics; Radiological traits; GLEASON SCORE; BIOPSY; RADIOMICS; CARCINOMA; AGREEMENT; DIAGNOSIS; PITFALLS; FEATURES; LEAD; MRI;
D O I
10.1186/s40644-019-0272-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Identification of imaging traits to discriminate clinically significant prostate cancer is challenging due to the multi focal nature of the disease. The difficulty in obtaining a consensus by the Prostate Imaging and Data Systems (PI-RADS) scores coupled with disagreements in interpreting multi-parametric Magnetic Resonance Imaging (mpMRI) has resulted in increased variability in reporting findings and evaluating the utility of this imaging modality in detecting clinically significant prostate cancer. This study assess the ability of radiological traits (semantics) observed on multi-parametric Magnetic Resonance images (mpMRI) to discriminate clinically significant prostate cancer. Methods: We obtained multi-parametric MRI studies from 103 prostate cancer patients with 167 targeted biopsies from a single institution. The study was approved by our Institutional Review Board (IRB) for retrospective analysis. The biopsy location had been identified and marked by a clinical radiologist for targeted biopsy based on initial study interpretation. Using the target locations, two study radiologists independently re-evaluated the scans and scored 16 semantic traits on a point scale (up to 5 levels) based on mpMRI images. The semantic traits describe size, shape, and border characteristics of the prostate lesion, as well as presence of disease around lymph nodes (lymphadenopathy). We built a linear classifier model on these semantic traits and related to pathological outcome to identify clinically significant tumors (Gleason Score >= 7). The discriminatory ability of the predictors was tested using cross validation method randomly repeated and ensemble values were reported. We then compared the performance of semantic predictors with the PI-RADS predictors. Results: We found several semantic features individually discriminated high grade Gleason score (ADC-intensity, Homogeneity, early-enhancement, T2-intensity and extraprostatic extention), these univariate predictors had an average area under the receiver operator characteristics (AUROC) ranging from 0.54 to 0.68. Multivariable semantic predictors with three features (ADC-intensity; T2-intensity, enhancement homogenicity) had an average AUROC of 0.7 [0.43, 0.94]. The PI-RADS based predictor had average AUROC of 0.6 [0.47, 0.75]. Conclusion: We find semantics traits are related to pathological findings with relatively higher reproducibility between radiologists. Multivariable predictors formed on these traits shows higher discriminatory ability compared to PI-RADS scores.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Considering Predictive Factors in the Diagnosis of Clinically Significant Prostate Cancer in Patients with PI-RADS 3 Lesions
    Natale, Caleb
    Koller, Christopher R.
    Greenberg, Jacob W.
    Pincus, Joshua
    Krane, Louis S.
    LIFE-BASEL, 2021, 11 (12):
  • [32] A two-stage model for precise identification and Gleason grading of clinically significant prostate cancer: a hybrid approach
    Zou, Yuyan
    Wang, Xuechun
    Ma, Fen
    Liu, Xulun
    Jiao, Chunyue
    Kang, Zhen
    Cui, Jingjing
    Zhang, Yang
    Xie, Yan
    Chen, Lei
    Tian, Ronghua
    JOURNAL OF MEDICAL RADIATION SCIENCES, 2025, 72 (01) : 93 - 105
  • [33] Comparisons of three scoring systems based on biparametric magnetic resonance imaging for prediction of clinically significant prostate cancer
    Li, Wei
    Xu, Haibing
    Shang, Wenwen
    Hong, Guohui
    PROSTATE INTERNATIONAL, 2024, 12 (04) : 201 - 206
  • [34] AI-predicted mpMRI image features for the prediction of clinically significant prostate cancer
    Li, Song
    Wang, Ke-Xin
    Li, Jia-Lei
    He, Yi
    Wang, Xiao-Ying
    Tang, Wen-Rui
    Xie, Wen-Hua
    Zhu, Wei
    Wu, Peng-Sheng
    Wang, Xiang-Peng
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (11) : 2703 - 2715
  • [35] Prediction of clinically significant prostate cancer with a multimodal MRI-based radiomics nomogram
    Jing, Guodong
    Xing, Pengyi
    Li, Zhihui
    Ma, Xiaolu
    Lu, Haidi
    Shao, Chengwei
    Lu, Yong
    Lu, Jianping
    Shen, Fu
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [36] Development and validation of nomogram to improve the specificity of multiparametric MRI for clinically significant prostate cancer
    Shiekh, Mohsin
    Houenstein, Holly
    Ramahi, Yousuf O. O.
    Shabir, Usma
    Ghadersohi, Sarah
    Zhu, Denzel
    Zhu, Michael
    Jing, Zhe
    Attwood, Kristopher
    Kauffman, Eric
    Aboumohamed, Ahmed
    Guru, Khurshid
    Hussein, Ahmed A. A.
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (10) : 876 - 882
  • [37] Evaluation of blood and urine based biomarkers for detection of clinically-significant prostate cancer
    Robinson, Hunter S.
    Lee, Sangmyung S.
    Barocas, Daniel A.
    Tosoian, Jeffrey J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2025, 28 (01) : 45 - 55
  • [38] Ruling out clinically significant prostate cancer with negative multi-parametric MRI
    An, Julie Y.
    Sidana, Abhinav
    Holzman, Sarah A.
    Baiocco, Joseph A.
    Mehralivand, Sherif
    Choyke, Peter L.
    Wood, Bradford J.
    Turkbey, Baris
    Pinto, Peter A.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2018, 50 (01) : 7 - 12
  • [39] The current value of histological findings in negative prostate biopsies to predict the future risk of clinically significant prostate cancer
    Schwartzmann, I
    Celma, A.
    Regis, L.
    Planas, J.
    Roche, S.
    de Torres, I. M.
    Semidey, M. E.
    Morote, J.
    ACTAS UROLOGICAS ESPANOLAS, 2021, 45 (06): : 447 - 454
  • [40] CLASSIFICATION OF PROSTATE CANCER: HIGH GRADE VERSUS LOW GRADE USING A RADIOMICS APPROACH
    Castillo, Jose M.
    Starmans, Martijn P. A.
    Niessen, Wiro J.
    Schoots, Ivo
    Klein, Stefan
    Veenland, Jifke F.
    2019 IEEE 16TH INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI 2019), 2019, : 1319 - 1322